Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1, 2)These patients are also more likely to experience poor functional outcomes. (3) 3) Rescue stenting (RS) in these patients has shown promising rates of recanalization and better outcomes in preliminary studies. Therefore, rescue stenting can be considered as a safe and viable option in these patients.

Stent 40

Stent Stents Stenosis Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:The Resolute Onyx stent has shown promise as an effective treatment for symptomatic intracranial atherosclerotic disease (sICAD), with positive clinical outcomes and low procedural complication rates. Stroke, Volume 55, Issue Suppl_1 , Page ATP185-ATP185, February 1, 2024.

Stent 40

Stent Stents Stenosis Hemorrhage 40

Stroke: Vascular and Interventional Neurology

JULY 6, 2023

BackgroundFor acute proximal intracranial artery occlusions, contact aspiration may be more effective than stent‐retriever for first‐line reperfusion therapy. stent‐retriever versus 55.5% stent‐retriever versus 55.5% stent‐retriever versus 55.5% versus 23.8%;P=0.10). versus 23.8%;P=0.10). versus 23.8%;P=0.10).

Stent 40

Stent Stents Thrombolysis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Background:Patients with atrial fibrillation were excluded from clinical trials evaluating carotid artery stent(CAS) or carotid endarterectomy (CEA).We We ascertained the end points of intra-procedural and post-procedural cerebral infarction, hemorrhage, discharge home and death in CAS and CEA patients with atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Stent Stents Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).

Angioplasty 40

Angioplasty Stent Stents Stenosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc., There was no restriction on time from last known well (TLKW) to MT.

Angioplasty 40

Angioplasty Stent Stents Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Intracerebral hemorrhage (ICH) is a main complication of IVT, with prevalence reported around 3.2% Additionally, extravasation of contrast was seen within the left basal ganglia region, concerning for hemorrhagic transformation from IV‐tPA. He underwent single pass complete recanalization, TICI 2C using Stent retriever and aspiration.

Hemorrhage 40

Hemorrhage Thrombolysis Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Rescue strategies options, including balloon angioplasty alone, rescue stenting (RS) alone, or stent with balloon angioplasty, have shown promise in observational studies and meta‐analyses [3, 4]. The primary efficacy outcome was the shift in the degree of disability, as measured by the modified Rankin Scale (mRS), at 90 days.

Stent 40

Stent Stents Angioplasty Thrombolysis 40

Stroke Journal

JANUARY 30, 2025

Background:Hyperperfusion phenomenon (HPP) constitutes a significant risk factor for adverse outcomes following carotid artery stenting (CAS). Stroke, Volume 56, Issue Suppl_1 , Page ATP178-ATP178, February 1, 2025. Currently, the sole method for evaluating the risk of HPP post-CAS is the invasive acetazolamide (ACZ) challenge test.

Stent 40

Stent Stents Risk Factors Stenosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. vs. 20.5%; p = 0.048) and stenting (28.4% We performed this retrospective cohort analysis to assess the impact of poorly controlled diabetes, defined as HbA1C of 9.0% or greater.

Outcomes 40

Outcomes Angioplasty Atrial Fibrillation Diabetes 40

Stroke Journal

JANUARY 30, 2025

Final infarct segmentation included hemorrhagic transformation. We compared demographics, radiological findings, clinical outcomes, and follow-up results between mismatch and no mismatch groups.Results:Among 73 patients, 20 (27.4%) had DWI-ADC mismatch. DWIR% = (DWIR/baseline DWI volume) 100 was calculated. P < 0.0001).

Outcomes 40

Outcomes Stroke Strokes Angioplasty 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 17, 2023

The primary outcome was the first‐pass effect (FPE), defined as expanded Treatment in Cerebral Infarction (TICI) 2c/3 on the first pass. FPE was associated with higher rates of favorable outcomes (modified Rankin scale score 0–2: 58% versus 43.4%;P=0.01; FPE was associated with better 90‐day clinical outcomes. 0.95];P=0.04).

Stent 40

Stent Stents Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, IVT's efficacy on stent retriever (SR) and aspiration thrombectomy (ASP) outcomes specifically remain unclear. Moreover, our results indicate that administration of IVT before MT may improve certain outcomes based on the used first‐line MT technique.

Thrombolysis 40

Thrombolysis Outcomes Embolism Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe optimal endovascular approach for wide‐neck intracranial aneurysms (IAs) during the acute phase of bleeding remains uncertain, and the use of stent‐assisted coiling or flow diversion is controversial due to antiplatelet therapy requirements and potential risks (1, 2). Of the patients, 60.5%

Aneurysm 40

Aneurysm Outcomes Hemorrhage Stents 40

Stroke: Vascular and Interventional Neurology

FEBRUARY 15, 2024

BACKGROUNDThe optimal endovascular approach for acutely ruptured wide‐neck intracranial aneurysms remains uncertain, and the use of stent‐assisted coiling or flow diversion is controversial due to antiplatelet therapy requirements and potential risks. P= 0.180) and hemorrhagic events (WEB: 3.8% P= 0.180) and hemorrhagic events (WEB: 3.8%

Aneurysm 40

Aneurysm Outcomes Hemorrhage Stents 40

Stroke Journal

FEBRUARY 1, 2024

The purpose of this study was to compare the outcomes of EVT for ICAD with those of cardiogenic cerebral embolism (CE) based on real-world data from a multicenter, prospective registry study (K-NET registry) involving 40 centers in Japan.Methods:The K-NET study enrolled 3187 EVTs in 2018-2021, of which 358 (11%) were ICAD and 1870 (59%) were CE.

Embolism 40

Embolism Outcomes Angioplasty Hemorrhage 40

Stroke: Vascular and Interventional Neurology

OCTOBER 2, 2023

BackgroundProcedural intravenous cangrelor has been proposed as an effective platelet inhibition strategy for stenting in acute ischemic stroke. Safety outcomes included rates of symptomatic intracranial hemorrhage, parenchymal hematoma type 2, petechial hemorrhage, and in‐stent thrombosis. 3.28];P=0.836).

Thrombosis 40

Thrombosis Hemorrhage Stents Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Angioplasty and stenting typically require the administration of glycoprotein IIb/IIIa inhibitors and/or dual‐antiplatelets which may increase the risk of hemorrhage in the setting of recent thrombolysis administration.MethodsWe conducted a retrospective analysis of a prospectively maintained patient registry at a comprehensive stroke center.

Angioplasty 40

Angioplasty Thrombolysis Hemorrhage Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Endovascular intervention was defined as either angioplasty, stenting, or a combination of both. Safety outcomes were comparable with similar rates of symptomatic intracranial hemorrhage (sICH).ConclusionWhile Symptomatic intracranial hemorrhage was low in medically treated patients.

Angioplasty 40

Angioplasty Stents Stent Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We therefore aim to characterize the antiplatelet regimens, and associated thromboembolic/hemorrhagic outcomes, utilized in patients with aneurysms treated with PED Shield.MethodsFactors including demographics, comorbidities, rupture status, devices placed, and antiplatelet regimen, among others, were collected.

Embolism 40

Embolism Aneurysm Hemorrhage Stents 40

Stroke Journal

FEBRUARY 1, 2024

We also compared the safety of acute carotid stenting (CAS) in TLs with low ASPECTS.Methods:This prospective multicenter study from 16 centers included patients with anterior circulation TL from 2015-2020. 5.02; p=0.86), petechial hemorrhages (OR: 0.79, CI: 0.10-6.05; in patients with stenting (18/44) versus no-stenting (25/44).Conclusion:This

Stents 40

Stents Stent Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Treatment of ICAS‐LVO with rescue stenting and/or angioplasty has shown promising outcomes, but diagnosing ICAS‐LVO during MT can be challenging [2, 3]. Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS) +/‐ angioplasty.

Atherosclerosis 40

Atherosclerosis Angioplasty Stents Stent 40

Stroke Journal

FEBRUARY 1, 2024

Functional, safety, and imaging outcomes were compared between patients in EVT vs. MM.Results:Of 352 enrolled, 100 (28%) had tandem occlusions, with 56 receiving EVT. TL Patients receiving EVT demonstrated significantly better functional outcomes (mRS at 90d: EVT 4[3-6] vs MM 5[4-6]; aGenOR: 2.22; 95%CI, 1.47-3.34; 0.90), p=0.009).

Stroke 40

Stroke Strokes Hemorrhage Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We compared baseline characteristics and completed a one‐way ANOVA to analyze for outcome measures such as in‐hospital mortality, 90‐day mortality, favorable functional outcome defined as modified Rankin Score (mRS) of 0‐2, at 90 days, symptomatic intracranial hemorrhage (sICH) and asymptomatic hemorrhage (aICH) between groups.

Stroke 40

Stroke Strokes Hemorrhage Academic 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionTo provide our single‐institution experience and outcome data with the WEB device in 51 patients treated for ruptured and unruptured intracranial aneurysms.MethodsOcclusion rates in a cohort of 51 patients treated with WEB were collected at time of procedure and at last follow‐up between the years 2019 and 2021.

Aneurysm 40

Aneurysm Embolism Hemorrhage Document 40

Stroke Journal

NOVEMBER 27, 2024

Novel NiTi-braided stent retriever (Venous-TD) is a dedicated venous sinus thrombectomy device. The primary efficacy outcome was the proportion of immediate complete recanalization during EVT. Secondary outcomes included the proportion of functional independence and moderate to severe residential headache at 180 days after EVT.

Thrombosis 40

Thrombosis Stents Stent Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe Advanced Neurovascular Access (ANA5, Anaconda Biomed) is a novel stroke thrombectomy catheter comprising a distal self‐expanding covered funnel designed to locally restrict blood flow in the Internal Carotid Artery (ICA) and, when used in conjuction with available stent retreiver, reduce clot fragmentation during clot ingestion.

Stents 40

Stents Stent Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

EVT consists of mechanical thrombectomy, thromboaspiration, balloon dilation, stenting, intra-arterial thrombolysis, or various combinations of these methods.

Thrombolysis 40

Thrombolysis Stroke Strokes Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Cases of unruptured intracranial aneurysms (UIA) are estimated to affect roughly 3% of the general population and aneurysmal subarachnoid hemorrhage (aSAH) have an incidence of 8 to 9 people per 100,000. IntroductionIntracranial aneurysms, both ruptured and unruptured, pose a significant risk to the general population.

Aneurysm 40

Aneurysm Embolism Stents Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionPrevious studies did not show a difference in terms of safety and efficacy among first‐line stent retriever (SR), contact aspiration (CA), or combined techniques for proximal large vessel occlusion strokes. The primary outcome was FPE defined as eTICI 2c/3 on the first pass. were female, with a mean age of 69.3

Stroke 40

Stroke Strokes Outcomes Stents 40

Stroke Journal

FEBRUARY 1, 2024

Primary effectiveness was complete occlusion (Raymond Roy Class 1) without retreatment at 1-year follow-up (core lab adjudicated), and primary safety was major stroke (ischemic/hemorrhagic) in the territory supplied by the target artery or death.Results:129 cases were included (median age 58 years, IQR: 50-67 years, 85% females). mm (IQR: 4.0-7.5)

Aneurysm 40

Aneurysm Stenosis Academic Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1,2 The National Institute of Health Stroke Scale (NIHSS) cutoff for poor outcomes is lower in BAO compared to anterior circulation large vessel occlusions (LVO) due to the scale’s weighted scoring towards cortical signs.3,4 3,4 To bridge this gap, Alemseged et.al 3,4 To bridge this gap, Alemseged et.al

Angioplasty 40

Angioplasty Stroke Strokes Circulation 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In light of postoperative CT head showing SAH in the basilar, perimesencephalic, prepontine cisterns, interhemispheric fissure and right frontal sulci as well as intraventricular hemorrhage in fourth ventricle, her presentation was thought to be secondary to cerebral vasospasm in the setting of postoperative SAH.

Blood Pressure 40

Blood Pressure Stenosis Hemorrhage Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionMechanical thrombectomy using stent retrievers and aspiration techniques has emerged as the standard of care for patients with acute ischemic stroke (AIS) secondary to emergent large vessel occlusion (LVO). The study presented high rates of good functional outcome at Day 90 and low rates of safety events.

Stroke 40

Stroke Strokes Embolism Stents 40

DAIC

JANUARY 22, 2024

Kown, Asan Medical Center, Seoul, Korea Golden Bridge II Effect of an Artificial Intelligence-Based Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients With Acute Ischemic Stroke : A Cluster-Randomized Clinical Trial: Zixiao Li, Beijing Tiantan Hospital, Capital Medical University, Beijing, China Friday, Feb.

Stroke 100

Stroke Strokes Hospital Stents 100

Stroke Journal

JANUARY 30, 2025

Background:Subarachnoid hemorrhage (SAH) following endovascular thrombectomy (EVT) is a poorly understood phenomenon, and whether it is associated with clinical detriment is unclear.Methods:This was an explorative analysis of a national database of real-world hospitalizations in the United States. vs. 10.6%, adjusted OR 2.53 [95%CI 2.23-2.87],

Hemorrhage 40

Hemorrhage Angioplasty Stents Stent 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Subarachnoid hemorrhage (SAH) following mechanical thrombectomy (MT) is not uncommon. Additionally, non-diffuse SAH group were significantly associated with significantly improved 90-day good functional outcomes defined as mRS 0-2 in unadjusted analysis (80% vs. 30%, OR 9.33, 95% CI 1.99-72.99, 102.05, p = 0.02).

Hemorrhage 40

Hemorrhage Outcomes Stents Stent 40